Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-31T15:19:19.866Z Has data issue: false hasContentIssue false
  • English
  • Français

Drowsiness and Antidepressant Drugs in Mild Depressive Illness

Published online by Cambridge University Press:  29 January 2018

David Wheatley
David Wheatley*
Affiliation:
Head of the General Practitioner Research Group, 325 Staines Road, Twickenham, Middlesex
Get access Rights & Permissions [Opens in a new window]

Extract

A sedative or tranquillizing effect may be important in the treatment of mild depressive illness not requiring admission to hospital or ECT (Wheatley, 1969), and Hare et al. (1962, 1964) have suggested that antidepressant drugs may exert their effect by virtue of their sedative action. Other workers also have found similar effects from antidepressant drugs and tranquillizers (Overall et al., 1964; Paykel, 1969).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 120 , Issue 558 , May 1972 , pp. 517 - 519
Copyright
Copyright © Royal College of Psychiatrists, 1972 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Clark, C. J., and Downie, C. C. (1966). ‘A method for the rapid determination of the number of patients to include in a controlled clinical trial.’ Lancet, ii, 1357.Google Scholar
Hare, E. H., Dominian, J., and Sharpe, L. (1962). ‘Phenelzine and dexamphetamine in depressive illness: a comparative trial.’ British Medical Journal, i, 9–12.CrossRefGoogle Scholar
Hare, E. H., McCance, C., and McCormick, W. O. (1964). ‘Imipramine and “Drinamyl” in depressive illness.’ British Medical Journal, i, 818–20.Google Scholar
General Practitioner Clinical Trials (1969). ‘Chlordiazepoxide with amitriptyline in neurotic depression.’ Practitioner, 202, 437–40.Google Scholar
General Practitioner Clinical Trials (1971). ‘Antidepressant effects of tranquillizers.’ Practitioner, 206, 146–8.Google Scholar
Overall, J. E., Hollister, L. E., Meyer, F., Kimbell, I., and Shelton, J. (1964). ‘Imipramine and thïoridazine in depressed and schizophrenic patients.’ Journal of the American Medical Association, 189, 605–8.Google ScholarPubMed
Paykel, E. S. (1969). ‘Imipramine and chlorpromazine: a comparative trial of their effects on the symptomatology of affective illness.’ Proceedings of the IV World Congress of Psychiatry, Madrid, pp. 2090–2. Excerpta Medica Foundation, Amsterdam.Google Scholar
Wheatley, D. (1969). ‘A comparative trial of imipramine and phenobarbital in depressed patients seen in general practice.’ Journal of Nervous and Mental Disease, 148, 542–9.Google Scholar
Wheatley, D. (1970). ‘Comparative trial of a new mono-amine oxidase inhibitor in depression.’ British Journal of Psychiatry, 117, 573–4.CrossRefGoogle ScholarPubMed
Wheatley, D. (1972). ‘Potentiation of amitriptyline by thyroid hormone.’ Archives of General Psychiatry. 26, Feb.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.